A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening-Reference-Cited by-同舟云学术

A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening

Published:2021-02 Issue:2 Volume:24 Page:102021
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Gorgulla Christoph^ORCID,Padmanabha Das Krishna M.,Leigh Kendra E.^ORCID,Cespugli Marco,Fischer Patrick D.,Wang Zi-Fu,Tesseyre Guilhem,Pandita Shreya,Shnapir Alec,Calderaio Anthony^ORCID,Gechev Minko,Rose Alexander^ORCID,Lewis Noam,Hutcheson Colin,Yaffe Erez,Luxenburg Roni,Herce Henry D.,Durmaz Vedat,Halazonetis Thanos D.,Fackeldey Konstantin,Patten J.J.^ORCID,Chuprina Alexander,Dziuba Igor,Plekhova Alla,Moroz Yurii,Radchenko Dmytro,Tarkhanova Olga,Yavnyuk Irina,Gruber Christian,Yust Ryan,Payne Dave^ORCID,Näär Anders M.,Namchuk Mark N.,Davey Robert A.^ORCID,Wagner Gerhard,Kinney Jamie^ORCID,Arthanari Haribabu

Funder

National Institute of Allergy and Infectious Diseases

National Institute of General Medical Sciences

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference228 articles.

1. Mechanism of nucleic acid unwinding by SARS-CoV helicase;Adedeji;PLoS One,2012

2. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia;Afar;Cancer Res.,2001

3. Coronavirus susceptibility to the antiviral Remdesivir (GS-5734) is mediated by the viral polymerase and the proofreading exoribonuclease;Agostini;mBio,2018

4. Small-molecule antiviral β-d-n4-hydroxycytidine inhibits a proofreading-intact coronavirus with a high genetic barrier to resistance;Agostini;J. Virol.,2019

5. Broad-spectrum coronavirus antiviral drug discovery;Allison;Expert Opin. Drug Discov.,2019

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DockOpt: A Tool for Automatic Optimization of Docking Models;Journal of Chemical Information and Modeling;2024-01-11

2. SARS-CoV-2-induced phosphorylation and its pharmacotherapy backed by artificial intelligence and machine learning;Future Science OA;2024-01-10

3. Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors;Acta Pharmaceutica Sinica B;2024-01

4. AI-assisted structural consensus-proteome prediction of human monkeypox viruses isolated within a year after the 2022 multi-country outbreak;Microbiology Spectrum;2023-12-12

5. Enhancing Ligand-Based Virtual Screening with 3D Shape Similarity via a Distance-Aware Transformer Model;2023-11-17